FGF21 and steatosis: Animals on HFD had an increased relative tissue surface of steatosis compared to animals on ND (3.29 vs 1.27%, p=<0.001), while the treatment with FGF21 had no effect on steatosis in the long-term (4.93 vs 3.29%, p = 0.46) (Figure 1G, H).